PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
PMC1184067	PMC1184067_0	[0]	[233]	['Preconception care by family physicians and general practitioners in Japan\n\nAbstract\n\nBackground\nPreconception care provided by family physicians/general practitioners (FP/GPs) can provide predictable benefits to mothers and infants.']	infants	UBERON_EXT	[225]	[232]	PMC1184067_T236
PMC1184067	PMC1184067_4	[748]	[827]	['Results\nTwo hundred and sixty-eight of 347 (77%) eligible physicians responded.']	responded	GO_BP_EXT	[817]	[826]	PMC1184067_T58
PMC1184067	PMC1184067_5	[828]	[970]	['The most common education they reported receiving was about smoking cessation (71%), and the least was about folic acid supplementation (12%).']	folic acid	CHEBI_EXT	[937]	[947]	PMC1184067_T0
PMC1184067	PMC1184067_6	[971]	[1128]	['Many participants reported providing smoking cessation in their practice (60%), though only about one third of respondents advise restricting alcohol intake.']	smoking	GO_BP_EXT	[1008]	[1015]	PMC1184067_T59
PMC1184067	PMC1184067_6	[971]	[1128]	['Many participants reported providing smoking cessation in their practice (60%), though only about one third of respondents advise restricting alcohol intake.']	alcohol	CHEBI_EXT	[1113]	[1120]	PMC1184067_T1
PMC1184067	PMC1184067_6	[971]	[1128]	['Many participants reported providing smoking cessation in their practice (60%), though only about one third of respondents advise restricting alcohol intake.']	intake	GO_BP_EXT	[1121]	[1127]	PMC1184067_T60
PMC1184067	PMC1184067_7	[1129]	[1216]	['Few reported advising calcium supplementation (10%) or folic acid supplementation (4%).']	calcium	CHEBI_EXT	[1151]	[1158]	PMC1184067_T2
PMC1184067	PMC1184067_7	[1129]	[1216]	['Few reported advising calcium supplementation (10%) or folic acid supplementation (4%).']	folic acid	CHEBI_EXT	[1184]	[1194]	PMC1184067_T3
PMC1184067	PMC1184067_10	[1397]	[1498]	['Conclusion\nFP/GPs in Japan report little training in preconception care and few currently provide it.']	preconception	GO_BP_EXT	[1450]	[1463]	PMC1184067_T61
PMC1184067	PMC1184067_12	[1658]	[1810]	['Background\nAppropriate preconception care provided by family physician/general practitioners (FP/GPs) can provide great benefits to mothers and infants.']	preconception	GO_BP_EXT	[1681]	[1694]	PMC1184067_T62
PMC1184067	PMC1184067_12	[1658]	[1810]	['Background\nAppropriate preconception care provided by family physician/general practitioners (FP/GPs) can provide great benefits to mothers and infants.']	infants	UBERON_EXT	[1802]	[1809]	PMC1184067_T237
PMC1184067	PMC1184067_13	[1811]	[2012]	['[1-4] In spite of many potentially helpful interventions prior to conception, there is little literature illustrating the effectiveness of preconception services delivery through primary care settings.']	conception	GO_BP_EXT	[1877]	[1887]	PMC1184067_T63
PMC1184067	PMC1184067_13	[1811]	[2012]	['[1-4] In spite of many potentially helpful interventions prior to conception, there is little literature illustrating the effectiveness of preconception services delivery through primary care settings.']	preconception	GO_BP_EXT	[1950]	[1963]	PMC1184067_T64
PMC1184067	PMC1184067_13	[1811]	[2012]	['[1-4] In spite of many potentially helpful interventions prior to conception, there is little literature illustrating the effectiveness of preconception services delivery through primary care settings.']	delivery	GO_BP_EXT	[1973]	[1981]	PMC1184067_T65
PMC1184067	PMC1184067_14	[2013]	[2159]	['Muchowski and Paladine present the evidence of effectiveness for components of preconception care that could be provided in primary care settings.']	preconception	GO_BP_EXT	[2092]	[2105]	PMC1184067_T66
PMC1184067	PMC1184067_15	[2159]	[2342]	['[4] Korenbrot and colleagues conducted a systematic review and found no RCTs of prepregnancy interventions, though one RCT was conducted among women who had a negative pregnancy test.']	prepregnancy	GO_BP_EXT	[2239]	[2251]	PMC1184067_T67
PMC1184067	PMC1184067_15	[2159]	[2342]	['[4] Korenbrot and colleagues conducted a systematic review and found no RCTs of prepregnancy interventions, though one RCT was conducted among women who had a negative pregnancy test.']	women	NCBITAXON_EXT	[2302]	[2307]	PMC1184067_T190
PMC1184067	PMC1184067_15	[2159]	[2342]	['[4] Korenbrot and colleagues conducted a systematic review and found no RCTs of prepregnancy interventions, though one RCT was conducted among women who had a negative pregnancy test.']	women	UBERON_EXT	[2302]	[2307]	PMC1184067_T238
PMC1184067	PMC1184067_15	[2159]	[2342]	['[4] Korenbrot and colleagues conducted a systematic review and found no RCTs of prepregnancy interventions, though one RCT was conducted among women who had a negative pregnancy test.']	pregnancy	GO_BP_EXT	[2327]	[2336]	PMC1184067_T68
PMC1184067	PMC1184067_16	[2342]	[2595]	["[5] Despite recent research demonstrating the importance of assessing primary care workers views on preconception care,[6] we found no published research on Japanese FP/GPs' approaches to the provision of preconception care to women of reproductive age."]	preconception	GO_BP_EXT	[2547]	[2560]	PMC1184067_T69
PMC1184067	PMC1184067_16	[2342]	[2595]	["[5] Despite recent research demonstrating the importance of assessing primary care workers views on preconception care,[6] we found no published research on Japanese FP/GPs' approaches to the provision of preconception care to women of reproductive age."]	women	NCBITAXON_EXT	[2569]	[2574]	PMC1184067_T191
PMC1184067	PMC1184067_16	[2342]	[2595]	["[5] Despite recent research demonstrating the importance of assessing primary care workers views on preconception care,[6] we found no published research on Japanese FP/GPs' approaches to the provision of preconception care to women of reproductive age."]	women	UBERON_EXT	[2569]	[2574]	PMC1184067_T239
PMC1184067	PMC1184067_16	[2342]	[2595]	["[5] Despite recent research demonstrating the importance of assessing primary care workers views on preconception care,[6] we found no published research on Japanese FP/GPs' approaches to the provision of preconception care to women of reproductive age."]	reproductive	GO_BP_EXT	[2578]	[2590]	PMC1184067_T70
PMC1184067	PMC1184067_17	[2596]	[2699]	['Such research is needed because obstetricians in Japan usually cannot provide preconception counseling.']	preconception	GO_BP_EXT	[2674]	[2687]	PMC1184067_T71
PMC1184067	PMC1184067_18	[2700]	[2808]	['Women infrequently present to OB/GYN physicians prior to conception unless they have gynecological problems.']	Women	NCBITAXON_EXT	[2700]	[2705]	PMC1184067_T192
PMC1184067	PMC1184067_18	[2700]	[2808]	['Women infrequently present to OB/GYN physicians prior to conception unless they have gynecological problems.']	Women	UBERON_EXT	[2700]	[2705]	PMC1184067_T240
PMC1184067	PMC1184067_18	[2700]	[2808]	['Women infrequently present to OB/GYN physicians prior to conception unless they have gynecological problems.']	conception	GO_BP_EXT	[2757]	[2767]	PMC1184067_T72
PMC1184067	PMC1184067_18	[2700]	[2808]	['Women infrequently present to OB/GYN physicians prior to conception unless they have gynecological problems.']	gynecological	UBERON_EXT	[2785]	[2798]	PMC1184067_T241
PMC1184067	PMC1184067_19	[2809]	[3013]	["Many of our primary care colleagues consider women's health issues to be outside the realm of their practice, and they lack systematic education in preventive care during family/general medicine training."]	women	NCBITAXON_EXT	[2854]	[2859]	PMC1184067_T193
PMC1184067	PMC1184067_19	[2809]	[3013]	["Many of our primary care colleagues consider women's health issues to be outside the realm of their practice, and they lack systematic education in preventive care during family/general medicine training."]	women	UBERON_EXT	[2854]	[2859]	PMC1184067_T242
PMC1184067	PMC1184067_20	[3014]	[3175]	['Despite a longstanding call for family physicians to provide preventive care in Japan,[7] we hypothesized that few FP/GPs are providing preconception counseling.']	preconception	GO_BP_EXT	[3150]	[3163]	PMC1184067_T73
PMC1184067	PMC1184067_21	[3176]	[3335]	['The best proven preconception intervention, taking folic acid supplements one to two months prior to conception, has been shown to prevent neural tube defects.']	preconception	GO_BP_EXT	[3192]	[3205]	PMC1184067_T74
PMC1184067	PMC1184067_21	[3176]	[3335]	['The best proven preconception intervention, taking folic acid supplements one to two months prior to conception, has been shown to prevent neural tube defects.']	folic acid	CHEBI_EXT	[3227]	[3237]	PMC1184067_T4
PMC1184067	PMC1184067_21	[3176]	[3335]	['The best proven preconception intervention, taking folic acid supplements one to two months prior to conception, has been shown to prevent neural tube defects.']	conception	GO_BP_EXT	[3277]	[3287]	PMC1184067_T75
PMC1184067	PMC1184067_21	[3176]	[3335]	['The best proven preconception intervention, taking folic acid supplements one to two months prior to conception, has been shown to prevent neural tube defects.']	neural tube	UBERON_EXT	[3315]	[3326]	PMC1184067_T243
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	pregnant	GO_BP_EXT	[3359]	[3367]	PMC1184067_T76
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	women	NCBITAXON_EXT	[3368]	[3373]	PMC1184067_T194
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	prenatal	GO_BP_EXT	[3408]	[3416]	PMC1184067_T77
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	pregnancy	GO_BP_EXT	[3443]	[3452]	PMC1184067_T78
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	fetal development	GO_BP_EXT	[3475]	[3492]	PMC1184067_T79
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	development of neural tube	GO_BP_EXT	[3515]	[3541]	PMC1184067_T80
PMC1184067	PMC1184067_22	[3335]	[3567]	['[8] Unfortunately, many pregnant women do not have their first visit for prenatal care until eight weeks of pregnancy or later, even though fetal development is most vulnerable to development of neural tube defects during this time.']	neural tube	UBERON_EXT	[3530]	[3541]	PMC1184067_T244
PMC1184067	PMC1184067_23	[3567]	[3766]	['[1] Epidemiological studies published over the last fifteen years document that prenatal supplementation with folic acid reduces the risk of neural tube defects, such as spina bifida and anencephaly.']	prenatal	GO_BP_EXT	[3647]	[3655]	PMC1184067_T81
PMC1184067	PMC1184067_23	[3567]	[3766]	['[1] Epidemiological studies published over the last fifteen years document that prenatal supplementation with folic acid reduces the risk of neural tube defects, such as spina bifida and anencephaly.']	folic acid	CHEBI_EXT	[3677]	[3687]	PMC1184067_T5
PMC1184067	PMC1184067_23	[3567]	[3766]	['[1] Epidemiological studies published over the last fifteen years document that prenatal supplementation with folic acid reduces the risk of neural tube defects, such as spina bifida and anencephaly.']	neural tube	UBERON_EXT	[3708]	[3719]	PMC1184067_T245
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	consumption	GO_BP_EXT	[3799]	[3810]	PMC1184067_T82
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	folic acid	CHEBI_EXT	[3824]	[3834]	PMC1184067_T6
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	reproductive	GO_BP_EXT	[3854]	[3866]	PMC1184067_T83
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	aged	GO_BP_EXT	[3867]	[3871]	PMC1184067_T84
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	women	NCBITAXON_EXT	[3872]	[3877]	PMC1184067_T195
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	women	UBERON_EXT	[3872]	[3877]	PMC1184067_T246
PMC1184067	PMC1184067_24	[3767]	[3957]	['[9-11] In many countries, daily consumption of 0.4 mg of folic acid is recommended for reproductive-aged women, and 4 mg is recommended for those who previously had an affected fetus/infant.']	infant	UBERON_EXT	[3950]	[3956]	PMC1184067_T247
PMC1184067	PMC1184067_25	[3957]	[4154]	['[12,13] The World Health Organization (WHO) recommends preconception care, including folic acid supplementation, for primary prevention of birth defects in developing and developed countries alike.']	preconception	GO_BP_EXT	[4012]	[4025]	PMC1184067_T85
PMC1184067	PMC1184067_25	[3957]	[4154]	['[12,13] The World Health Organization (WHO) recommends preconception care, including folic acid supplementation, for primary prevention of birth defects in developing and developed countries alike.']	folic acid	CHEBI_EXT	[4042]	[4052]	PMC1184067_T7
PMC1184067	PMC1184067_25	[3957]	[4154]	['[12,13] The World Health Organization (WHO) recommends preconception care, including folic acid supplementation, for primary prevention of birth defects in developing and developed countries alike.']	birth	GO_BP_EXT	[4096]	[4101]	PMC1184067_T86
PMC1184067	PMC1184067_26	[4154]	[4279]	['[14]\nUntil recently, there has been no recommendation for Japanese women to take a folic acid supplement prior to conception.']	women	NCBITAXON_EXT	[4221]	[4226]	PMC1184067_T196
PMC1184067	PMC1184067_26	[4154]	[4279]	['[14]\nUntil recently, there has been no recommendation for Japanese women to take a folic acid supplement prior to conception.']	women	UBERON_EXT	[4221]	[4226]	PMC1184067_T248
PMC1184067	PMC1184067_26	[4154]	[4279]	['[14]\nUntil recently, there has been no recommendation for Japanese women to take a folic acid supplement prior to conception.']	folic acid	CHEBI_EXT	[4237]	[4247]	PMC1184067_T8
PMC1184067	PMC1184067_26	[4154]	[4279]	['[14]\nUntil recently, there has been no recommendation for Japanese women to take a folic acid supplement prior to conception.']	conception	GO_BP_EXT	[4268]	[4278]	PMC1184067_T87
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	reproductive	GO_BP_EXT	[4386]	[4398]	PMC1184067_T88
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	aged	GO_BP_EXT	[4399]	[4403]	PMC1184067_T89
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	women	NCBITAXON_EXT	[4404]	[4409]	PMC1184067_T197
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	women	UBERON_EXT	[4404]	[4409]	PMC1184067_T249
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	folic acid	CHEBI_EXT	[4417]	[4427]	PMC1184067_T9
PMC1184067	PMC1184067_27	[4280]	[4486]	['In December 2000, the Ministry of Health, Labour and Welfare (MHLW) formally recognized the importance of reproductive-aged women taking folic acid supplementation for the prevention of neural tube defects.']	neural tube	UBERON_EXT	[4466]	[4477]	PMC1184067_T250
PMC1184067	PMC1184067_28	[4486]	[4685]	['[15] This recommendation was based on research showing that the rate of neural tube defects is reduced by about 72% when women take folic acid supplementation one to three months prior to conception.']	neural tube	UBERON_EXT	[4558]	[4569]	PMC1184067_T251
PMC1184067	PMC1184067_28	[4486]	[4685]	['[15] This recommendation was based on research showing that the rate of neural tube defects is reduced by about 72% when women take folic acid supplementation one to three months prior to conception.']	women	NCBITAXON_EXT	[4607]	[4612]	PMC1184067_T198
PMC1184067	PMC1184067_28	[4486]	[4685]	['[15] This recommendation was based on research showing that the rate of neural tube defects is reduced by about 72% when women take folic acid supplementation one to three months prior to conception.']	women	UBERON_EXT	[4607]	[4612]	PMC1184067_T252
PMC1184067	PMC1184067_28	[4486]	[4685]	['[15] This recommendation was based on research showing that the rate of neural tube defects is reduced by about 72% when women take folic acid supplementation one to three months prior to conception.']	folic acid	CHEBI_EXT	[4618]	[4628]	PMC1184067_T10
PMC1184067	PMC1184067_28	[4486]	[4685]	['[15] This recommendation was based on research showing that the rate of neural tube defects is reduced by about 72% when women take folic acid supplementation one to three months prior to conception.']	conception	GO_BP_EXT	[4674]	[4684]	PMC1184067_T90
PMC1184067	PMC1184067_29	[4686]	[4960]	['The MHLW recommended to the Japan Medical Association, Japan Society of Obstetrics and Gynecology, and Japan Pediatric Society that these organizations should provide their membership with adequate information about the value of taking folic acid to reproductive-aged women.']	folic acid	CHEBI_EXT	[4922]	[4932]	PMC1184067_T11
PMC1184067	PMC1184067_29	[4686]	[4960]	['The MHLW recommended to the Japan Medical Association, Japan Society of Obstetrics and Gynecology, and Japan Pediatric Society that these organizations should provide their membership with adequate information about the value of taking folic acid to reproductive-aged women.']	reproductive	GO_BP_EXT	[4936]	[4948]	PMC1184067_T91
PMC1184067	PMC1184067_29	[4686]	[4960]	['The MHLW recommended to the Japan Medical Association, Japan Society of Obstetrics and Gynecology, and Japan Pediatric Society that these organizations should provide their membership with adequate information about the value of taking folic acid to reproductive-aged women.']	aged	GO_BP_EXT	[4949]	[4953]	PMC1184067_T92
PMC1184067	PMC1184067_29	[4686]	[4960]	['The MHLW recommended to the Japan Medical Association, Japan Society of Obstetrics and Gynecology, and Japan Pediatric Society that these organizations should provide their membership with adequate information about the value of taking folic acid to reproductive-aged women.']	women	NCBITAXON_EXT	[4954]	[4959]	PMC1184067_T199
PMC1184067	PMC1184067_29	[4686]	[4960]	['The MHLW recommended to the Japan Medical Association, Japan Society of Obstetrics and Gynecology, and Japan Pediatric Society that these organizations should provide their membership with adequate information about the value of taking folic acid to reproductive-aged women.']	women	UBERON_EXT	[4954]	[4959]	PMC1184067_T253
PMC1184067	PMC1184067_30	[4960]	[5111]	['[15]\nIn addition, there are other compelling topics to cover during preconception counseling based on theoretical considerations and indirect evidence.']	preconception	GO_BP_EXT	[5028]	[5041]	PMC1184067_T93
PMC1184067	PMC1184067_33	[5255]	[5411]	['[16] Rubella vaccination is not mandatory due in part to serious side effects that resulted from an MMR vaccination manufactured in Japan several years ago.']	Rubella	NCBITAXON_EXT	[5260]	[5267]	PMC1184067_T200
PMC1184067	PMC1184067_34	[5411]	[5510]	['[16] Antibody negative women can be safely vaccinated prior to pregnancy during preconception care.']	Antibody	GO_CC_EXT	[5416]	[5424]	PMC1184067_T177
PMC1184067	PMC1184067_34	[5411]	[5510]	['[16] Antibody negative women can be safely vaccinated prior to pregnancy during preconception care.']	women	NCBITAXON_EXT	[5434]	[5439]	PMC1184067_T201
PMC1184067	PMC1184067_34	[5411]	[5510]	['[16] Antibody negative women can be safely vaccinated prior to pregnancy during preconception care.']	women	UBERON_EXT	[5434]	[5439]	PMC1184067_T254
PMC1184067	PMC1184067_34	[5411]	[5510]	['[16] Antibody negative women can be safely vaccinated prior to pregnancy during preconception care.']	pregnancy	GO_BP_EXT	[5474]	[5483]	PMC1184067_T94
PMC1184067	PMC1184067_34	[5411]	[5510]	['[16] Antibody negative women can be safely vaccinated prior to pregnancy during preconception care.']	preconception	GO_BP_EXT	[5491]	[5504]	PMC1184067_T95
PMC1184067	PMC1184067_35	[5510]	[5587]	['[17]\nExcessive alcohol intake during pregnancy causes fetal alcohol syndrome.']	alcohol	CHEBI_EXT	[5525]	[5532]	PMC1184067_T12
PMC1184067	PMC1184067_35	[5510]	[5587]	['[17]\nExcessive alcohol intake during pregnancy causes fetal alcohol syndrome.']	intake	GO_BP_EXT	[5533]	[5539]	PMC1184067_T96
PMC1184067	PMC1184067_35	[5510]	[5587]	['[17]\nExcessive alcohol intake during pregnancy causes fetal alcohol syndrome.']	pregnancy	GO_BP_EXT	[5547]	[5556]	PMC1184067_T97
PMC1184067	PMC1184067_35	[5510]	[5587]	['[17]\nExcessive alcohol intake during pregnancy causes fetal alcohol syndrome.']	alcohol	CHEBI_EXT	[5570]	[5577]	PMC1184067_T13
PMC1184067	PMC1184067_36	[5587]	[5659]	['[18] Smoking during pregnancy is associated with low birth rate infants.']	pregnancy	GO_BP_EXT	[5607]	[5616]	PMC1184067_T98
PMC1184067	PMC1184067_36	[5587]	[5659]	['[18] Smoking during pregnancy is associated with low birth rate infants.']	birth	GO_BP_EXT	[5640]	[5645]	PMC1184067_T99
PMC1184067	PMC1184067_36	[5587]	[5659]	['[18] Smoking during pregnancy is associated with low birth rate infants.']	infants	UBERON_EXT	[5651]	[5658]	PMC1184067_T255
PMC1184067	PMC1184067_37	[5659]	[5872]	['[19] As post-partum hemorrhage is the most important cause of preventable maternal mortality in Japan,[20] prevention of anemia through early detection and treatment with iron supplementation merits consideration.']	partum	GO_BP_EXT	[5672]	[5678]	PMC1184067_T100
PMC1184067	PMC1184067_37	[5659]	[5872]	['[19] As post-partum hemorrhage is the most important cause of preventable maternal mortality in Japan,[20] prevention of anemia through early detection and treatment with iron supplementation merits consideration.']	iron	CHEBI_EXT	[5830]	[5834]	PMC1184067_T14
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	calcium	CHEBI_EXT	[5898]	[5905]	PMC1184067_T15
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	reproductive	GO_BP_EXT	[5921]	[5933]	PMC1184067_T101
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	women	NCBITAXON_EXT	[5934]	[5939]	PMC1184067_T202
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	calcium	CHEBI_EXT	[5988]	[5995]	PMC1184067_T16
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	women	NCBITAXON_EXT	[6048]	[6053]	PMC1184067_T203
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	childbearing	GO_BP_EXT	[6057]	[6069]	PMC1184067_T102
PMC1184067	PMC1184067_38	[5873]	[6074]	['As the average intake of calcium, especially in reproductive women in Japan, is lower than recommended in general, calcium intake is a particularly salient issue for Japanese women of childbearing age.']	childbearing	UBERON_EXT	[6057]	[6069]	PMC1184067_T256
PMC1184067	PMC1184067_39	[6075]	[6219]	['Though controversial, exercise, and mechanisms to optimize pregnancy are among other potentially beneficial effects of preconception counseling.']	pregnancy	GO_BP_EXT	[6134]	[6143]	PMC1184067_T103
PMC1184067	PMC1184067_39	[6075]	[6219]	['Though controversial, exercise, and mechanisms to optimize pregnancy are among other potentially beneficial effects of preconception counseling.']	preconception	GO_BP_EXT	[6194]	[6207]	PMC1184067_T104
PMC1184067	PMC1184067_40	[6220]	[6522]	['[1-4] Based on clinical experience with a large population of Japanese couples desiring pregnancy, but having difficulty conceiving and not willing to see an infertility specialist, we consider brief counseling on basal body temperature monitoring and timing of intercourse as topics relevant in Japan.']	pregnancy	GO_BP_EXT	[6308]	[6317]	PMC1184067_T105
PMC1184067	PMC1184067_40	[6220]	[6522]	['[1-4] Based on clinical experience with a large population of Japanese couples desiring pregnancy, but having difficulty conceiving and not willing to see an infertility specialist, we consider brief counseling on basal body temperature monitoring and timing of intercourse as topics relevant in Japan.']	conceiving	GO_BP_EXT	[6341]	[6351]	PMC1184067_T106
PMC1184067	PMC1184067_40	[6220]	[6522]	['[1-4] Based on clinical experience with a large population of Japanese couples desiring pregnancy, but having difficulty conceiving and not willing to see an infertility specialist, we consider brief counseling on basal body temperature monitoring and timing of intercourse as topics relevant in Japan.']	body	UBERON_EXT	[6440]	[6444]	PMC1184067_T257
PMC1184067	PMC1184067_40	[6220]	[6522]	['[1-4] Based on clinical experience with a large population of Japanese couples desiring pregnancy, but having difficulty conceiving and not willing to see an infertility specialist, we consider brief counseling on basal body temperature monitoring and timing of intercourse as topics relevant in Japan.']	intercourse	GO_BP_EXT	[6482]	[6493]	PMC1184067_T107
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	child	NCBITAXON_EXT	[6572]	[6577]	PMC1184067_T204
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	child	UBERON_EXT	[6572]	[6577]	PMC1184067_T258
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	reproductive	GO_BP_EXT	[6707]	[6719]	PMC1184067_T108
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	aged	GO_BP_EXT	[6720]	[6724]	PMC1184067_T109
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	women	NCBITAXON_EXT	[6725]	[6730]	PMC1184067_T205
PMC1184067	PMC1184067_41	[6523]	[6750]	['Given the importance of these issues in maternal child health, the purpose of this research was to elucidate the knowledge of, attitudes about, and practices of preconception care for reproductive-aged women by FP/GPs in Japan.']	women	UBERON_EXT	[6725]	[6730]	PMC1184067_T259
PMC1184067	PMC1184067_57	[8789]	[8979]	['Some are compelling based on best evidence (such as folic acid supplementation, smoking cessation),[5] while others were chosen based on circumstances particular to Japan as presented above.']	folic acid	CHEBI_EXT	[8841]	[8851]	PMC1184067_T17
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	Preconception	GO_BP_EXT	[9012]	[9025]	PMC1184067_T110
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	acid	CHEBI_EXT	[9070]	[9074]	PMC1184067_T18
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	folic acid	CHEBI_EXT	[9107]	[9117]	PMC1184067_T19
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	pregnancy	GO_BP_EXT	[9142]	[9151]	PMC1184067_T111
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	neural	UBERON_EXT	[9157]	[9163]	PMC1184067_T260
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	conception	GO_BP_EXT	[9199]	[9209]	PMC1184067_T112
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	pregnancy	GO_BP_EXT	[9269]	[9278]	PMC1184067_T113
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	iron	CHEBI_EXT	[9363]	[9367]	PMC1184067_T20
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	rubella	NCBITAXON_EXT	[9413]	[9420]	PMC1184067_T206
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	antibodyCheck	GO_CC_EXT	[9421]	[9434]	PMC1184067_T178
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	IgG	GO_CC_EXT	[9435]	[9438]	PMC1184067_T179
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	rubella	NCBITAXON_EXT	[9439]	[9446]	PMC1184067_T207
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	antibody	GO_CC_EXT	[9447]	[9455]	PMC1184067_T180
PMC1184067	PMC1184067_58	[8981]	[9474]	['Caption (TABLE-WRAP): TABLE 1\n\nPreconception Care InterventionsServicesInterventionFolic acid supplementationAdvise 0.4 mg of folic acid daily (4 mg if previous pregnancy with neural tube defect) three months prior to conception.Smoking cessationEducate about the risks of smoking during pregnancy and counsel about smoking cessation.Anemia screenCheck hematocrit/CBC and recommend iron supplement if anemia is detected.Testing for rubella antibodyCheck IgG rubella antibody before conception.']	conception	GO_BP_EXT	[9463]	[9473]	PMC1184067_T114
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	conception	GO_BP_EXT	[9520]	[9530]	PMC1184067_T115
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	Alcohol	CHEBI_EXT	[9548]	[9555]	PMC1184067_T21
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	caffeineRestrict	CHEBI_EXT	[9677]	[9693]	PMC1184067_T22
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	caffeine	CHEBI_EXT	[9694]	[9702]	PMC1184067_T23
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	pregnancy	GO_BP_EXT	[9798]	[9807]	PMC1184067_T116
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	Calcium	CHEBI_EXT	[9808]	[9815]	PMC1184067_T24
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	calcium	CHEBI_EXT	[9838]	[9845]	PMC1184067_T25
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	body	UBERON_EXT	[9921]	[9925]	PMC1184067_T261
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	body	UBERON_EXT	[9952]	[9956]	PMC1184067_T262
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	ovulation	GO_BP_EXT	[10006]	[10015]	PMC1184067_T117
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	intercourse	GO_BP_EXT	[10026]	[10037]	PMC1184067_T118
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	intercourse	GO_BP_EXT	[10045]	[10056]	PMC1184067_T119
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	ovulation	GO_BP_EXT	[10088]	[10097]	PMC1184067_T120
PMC1184067	PMC1184067_59	[9475]	[10132]	['If the test is negative, vaccinate and avoid conception for three months.Alcohol restrictionScreen for alcoholism by using a validated questionnaire, and counsel or refer if positive screen.Restricting caffeineRestrict caffeine intake to less than 250 mg a day.ExerciseAdvise regular to moderate exercise before and during pregnancy.Calcium supplementationAssess calcium intake and as needed supplement for a target of 1200 mg daily.Use of basal body temperature*Conduct basal body temperature every morning to identify the day of ovulation.Timing of intercourse*Advise intercourse every other day around time of ovulation to maximize chances of conception.']	conception	GO_BP_EXT	[10121]	[10131]	PMC1184067_T121
PMC1184067	PMC1184067_60	[10133]	[10249]	['*For couples having difficulty conceiving\nWe analyzed the data using SPSS (Statistical Package for Social Sciences).']	conceiving	GO_BP_EXT	[10164]	[10174]	PMC1184067_T122
PMC1184067	PMC1184067_65	[10781]	[10871]	['Of the 386 physicians to whom we distributed instruments, 291 physician members responded.']	responded	GO_BP_EXT	[10861]	[10870]	PMC1184067_T123
PMC1184067	PMC1184067_68	[11045]	[11144]	['Thus, 268 of 347 eligible physicians (response rate 77.2%) were included in the analysis (Figure1).']	response	GO_BP_EXT	[11083]	[11091]	PMC1184067_T124
PMC1184067	PMC1184067_70	[11204]	[11261]	['Most were men (86%) and the mean age was almost 40 years.']	men	UBERON_EXT	[11214]	[11217]	PMC1184067_T263
PMC1184067	PMC1184067_71	[11262]	[11335]	['Most physicians reported seeing reproductive-aged women in their offices.']	reproductive	GO_BP_EXT	[11294]	[11306]	PMC1184067_T125
PMC1184067	PMC1184067_71	[11262]	[11335]	['Most physicians reported seeing reproductive-aged women in their offices.']	women	NCBITAXON_EXT	[11312]	[11317]	PMC1184067_T208
PMC1184067	PMC1184067_71	[11262]	[11335]	['Most physicians reported seeing reproductive-aged women in their offices.']	women	UBERON_EXT	[11312]	[11317]	PMC1184067_T264
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	Reproductive	GO_BP_EXT	[11890]	[11902]	PMC1184067_T126
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	women11	NCBITAXON_EXT	[11903]	[11910]	PMC1184067_T209
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	Child	UBERON_EXT	[11949]	[11954]	PMC1184067_T265
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	Adolescence	GO_BP_EXT	[11972]	[11983]	PMC1184067_T127
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	Adult	UBERON_EXT	[12001]	[12006]	PMC1184067_T266
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	responses	GO_BP_EXT	[12068]	[12077]	PMC1184067_T128
PMC1184067	PMC1184067_72	[11337]	[12266]	['Caption (TABLE-WRAP): TABLE 2\n\nParticipant Demographics (n = 268)n(%)Gender\u2003\u2003Male230(85.8)Age\u2003\u2003Mean (range)40.1 (2573)Period after graduating from med school (yrs)\u2003\u2003Mean (range)14.4 (126)Specialty (total response = 308)*\u2003\u2003General Internal Medicine140(45.5)\u2003\u2003Family Medicine102(33.1)\u2003\u2003Specialty in Internal Medicine19(6.2)\u2003\u2003General Medicine10(3.2)\u2003Surgery8(2.6)\u2003\u2003Pediatrics8(2.6)\u2003\u2003Psychiatry6(1.9)\u2003\u2003Orthopedics5(1.6)\u2003\u2003Others10(3.2)Experiences of out-patient training in\u2003Pediatrics160(59.7)\u2003OB/GYN99(36.9)Average number of patients per week\u2003\u2003All142 /wk\u2003Reproductive women11 /wkAverage number of patients by age\u2003\u2003Child (015)15.3(8.9)\u2003\u2003Adolescence (1619)9.5(7.0)\u2003\u2003Adult (2064)43.9(35.0)\u2003\u2003Elderly (65 and more)69.5(49.4)\n*multiple responses were possible\nWith regard to educational experiences in preconception counseling during medical school and residency training (Table3), most participants reported they had received little.']	preconception	GO_BP_EXT	[12134]	[12147]	PMC1184067_T129
PMC1184067	PMC1184067_73	[12267]	[12433]	['The most common relevant training they reported receiving included: smoking cessation (71%), screening for anemia (64%), and blood testing for rubella antibody (58%).']	blood	UBERON_EXT	[12392]	[12397]	PMC1184067_T267
PMC1184067	PMC1184067_73	[12267]	[12433]	['The most common relevant training they reported receiving included: smoking cessation (71%), screening for anemia (64%), and blood testing for rubella antibody (58%).']	rubella	NCBITAXON_EXT	[12410]	[12417]	PMC1184067_T210
PMC1184067	PMC1184067_73	[12267]	[12433]	['The most common relevant training they reported receiving included: smoking cessation (71%), screening for anemia (64%), and blood testing for rubella antibody (58%).']	antibody	GO_CC_EXT	[12418]	[12426]	PMC1184067_T181
PMC1184067	PMC1184067_74	[12434]	[12613]	['Few reported training experiences in providing folic acid supplementation (12%), timing of intercourse to maximize chances of conception (14%), or exercise during pregnancy (18%).']	folic acid	CHEBI_EXT	[12481]	[12491]	PMC1184067_T26
PMC1184067	PMC1184067_74	[12434]	[12613]	['Few reported training experiences in providing folic acid supplementation (12%), timing of intercourse to maximize chances of conception (14%), or exercise during pregnancy (18%).']	conception	GO_BP_EXT	[12560]	[12570]	PMC1184067_T130
PMC1184067	PMC1184067_74	[12434]	[12613]	['Few reported training experiences in providing folic acid supplementation (12%), timing of intercourse to maximize chances of conception (14%), or exercise during pregnancy (18%).']	pregnancy	GO_BP_EXT	[12597]	[12606]	PMC1184067_T131
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	Blood	UBERON_EXT	[12824]	[12829]	PMC1184067_T268
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	rubella	NCBITAXON_EXT	[12842]	[12849]	PMC1184067_T211
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	antibody156	GO_CC_EXT	[12850]	[12861]	PMC1184067_T182
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	body	UBERON_EXT	[12880]	[12884]	PMC1184067_T269
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	alcohol	CHEBI_EXT	[12928]	[12935]	PMC1184067_T27
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	calcium	CHEBI_EXT	[12962]	[12969]	PMC1184067_T28
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	caffeine	CHEBI_EXT	[12996]	[13004]	PMC1184067_T29
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	pregnancy48	GO_BP_EXT	[13035]	[13046]	PMC1184067_T132
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	intercourse	GO_BP_EXT	[13062]	[13073]	PMC1184067_T133
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	conception38	GO_BP_EXT	[13097]	[13109]	PMC1184067_T134
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	Folic acid	CHEBI_EXT	[13115]	[13125]	PMC1184067_T30
PMC1184067	PMC1184067_75	[12615]	[13221]	["Caption (TABLE-WRAP): TABLE 3\n\nJapanese family physicians' experiences in preconception education during medical school and residency training (n = 268)n(%)Smoking cessation191(71.3)Testing for anemia172(64.2)Blood testing for rubella antibody156(58.2)Use of basal body temperature monitoring125(46.6)Restricting alcohol intake120(44.8)Increasing calcium intake86(32.1)Restricting caffeine intake52(19.4)Exercise during pregnancy48(17.9)Timing of intercourse to maximize chances of conception38(14.2)Folic acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in Table4."]	Preconception	GO_BP_EXT	[13150]	[13163]	PMC1184067_T135
PMC1184067	PMC1184067_76	[13222]	[13329]	['Many participants reported often or always addressing smoking cessation with reproductive-aged women (60%).']	smoking	GO_BP_EXT	[13276]	[13283]	PMC1184067_T136
PMC1184067	PMC1184067_76	[13222]	[13329]	['Many participants reported often or always addressing smoking cessation with reproductive-aged women (60%).']	reproductive	GO_BP_EXT	[13299]	[13311]	PMC1184067_T137
PMC1184067	PMC1184067_76	[13222]	[13329]	['Many participants reported often or always addressing smoking cessation with reproductive-aged women (60%).']	women	NCBITAXON_EXT	[13317]	[13322]	PMC1184067_T212
PMC1184067	PMC1184067_77	[13330]	[13438]	['Some reported they provide screening for anemia (35%) and counseling about restricting alcohol intake (27%).']	alcohol	CHEBI_EXT	[13417]	[13424]	PMC1184067_T31
PMC1184067	PMC1184067_78	[13439]	[13557]	['Few reported they addressed either calcium intake through foods/supplements (10%), or folic acid supplementation (4%).']	calcium	CHEBI_EXT	[13474]	[13481]	PMC1184067_T32
PMC1184067	PMC1184067_78	[13439]	[13557]	['Few reported they addressed either calcium intake through foods/supplements (10%), or folic acid supplementation (4%).']	intake	GO_BP_EXT	[13482]	[13488]	PMC1184067_T138
PMC1184067	PMC1184067_78	[13439]	[13557]	['Few reported they addressed either calcium intake through foods/supplements (10%), or folic acid supplementation (4%).']	foods	CHEBI_EXT	[13497]	[13502]	PMC1184067_T33
PMC1184067	PMC1184067_78	[13439]	[13557]	['Few reported they addressed either calcium intake through foods/supplements (10%), or folic acid supplementation (4%).']	folic acid	CHEBI_EXT	[13525]	[13535]	PMC1184067_T34
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	preconception	GO_BP_EXT	[13634]	[13647]	PMC1184067_T139
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	Responsen	GO_BP_EXT	[13731]	[13740]	PMC1184067_T140
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	Timing	GO_BP_EXT	[13755]	[13761]	PMC1184067_T141
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	intercourse	GO_BP_EXT	[13765]	[13776]	PMC1184067_T142
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	conception222	GO_BP_EXT	[13800]	[13813]	PMC1184067_T143
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	Folic acid	CHEBI_EXT	[13839]	[13849]	PMC1184067_T35
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	pregnancy198	GO_BP_EXT	[13911]	[13923]	PMC1184067_T144
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	rubella	NCBITAXON_EXT	[13963]	[13970]	PMC1184067_T213
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	antibody180	GO_CC_EXT	[13971]	[13982]	PMC1184067_T183
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	calcium	CHEBI_EXT	[14021]	[14028]	PMC1184067_T36
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	caffeine	CHEBI_EXT	[14079]	[14087]	PMC1184067_T37
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	body	UBERON_EXT	[14139]	[14143]	PMC1184067_T270
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	alcohol	CHEBI_EXT	[14210]	[14217]	PMC1184067_T38
PMC1184067	PMC1184067_79	[13559]	[14428]	["Caption (TABLE-WRAP): TABLE 4\n\nJapanese family physicians' self-reports of preconception care in their clinical practice (n = 268)Never/Almost NeverSometimesOften/AlwaysNo Responsen(%)n(%)n(%)n(%)Timing of intercourse to maximize chances of conception222(82.8)20(7.5)9(3.6)17(6.3)Folic acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)Exercise during pregnancy198(73.9)32(11.9)20(7.5)18(6.7)Testing for rubella antibody180(67.2)55(20.5)21(7.8)12(4.5)Increasing calcium intake168(62.7)61(22.7)27(10.1)12(4.5)Restricting caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)Use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)Restricting alcohol intake107(39.9)74(27.6)72(26.9)15(5.6)Testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)Smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\nTheir attitudes about providing preconception care are depicted in Table5."]	intake107	GO_BP_EXT	[14218]	[14227]	PMC1184067_T145
PMC1184067	PMC1184067_80	[14429]	[14642]	['About two thirds of participants reported their willingness to provide preconception care about such topics as calcium intake (70%), blood testing for rubella antibody (69%), and restricting caffeine intake (64%).']	calcium	CHEBI_EXT	[14540]	[14547]	PMC1184067_T39
PMC1184067	PMC1184067_80	[14429]	[14642]	['About two thirds of participants reported their willingness to provide preconception care about such topics as calcium intake (70%), blood testing for rubella antibody (69%), and restricting caffeine intake (64%).']	blood	UBERON_EXT	[14562]	[14567]	PMC1184067_T271
PMC1184067	PMC1184067_80	[14429]	[14642]	['About two thirds of participants reported their willingness to provide preconception care about such topics as calcium intake (70%), blood testing for rubella antibody (69%), and restricting caffeine intake (64%).']	rubella	NCBITAXON_EXT	[14580]	[14587]	PMC1184067_T214
PMC1184067	PMC1184067_80	[14429]	[14642]	['About two thirds of participants reported their willingness to provide preconception care about such topics as calcium intake (70%), blood testing for rubella antibody (69%), and restricting caffeine intake (64%).']	antibody	GO_CC_EXT	[14588]	[14596]	PMC1184067_T184
PMC1184067	PMC1184067_80	[14429]	[14642]	['About two thirds of participants reported their willingness to provide preconception care about such topics as calcium intake (70%), blood testing for rubella antibody (69%), and restricting caffeine intake (64%).']	caffeine	CHEBI_EXT	[14620]	[14628]	PMC1184067_T40
PMC1184067	PMC1184067_81	[14643]	[14829]	['On the other hand, some expressed dissatisfaction with counseling about timing of intercourse to maximize chances of conception (46%), and use of basal body temperature monitoring (22%).']	intercourse	GO_BP_EXT	[14725]	[14736]	PMC1184067_T146
PMC1184067	PMC1184067_81	[14643]	[14829]	['On the other hand, some expressed dissatisfaction with counseling about timing of intercourse to maximize chances of conception (46%), and use of basal body temperature monitoring (22%).']	conception	GO_BP_EXT	[14760]	[14770]	PMC1184067_T147
PMC1184067	PMC1184067_81	[14643]	[14829]	['On the other hand, some expressed dissatisfaction with counseling about timing of intercourse to maximize chances of conception (46%), and use of basal body temperature monitoring (22%).']	body	UBERON_EXT	[14795]	[14799]	PMC1184067_T272
PMC1184067	PMC1184067_82	[14830]	[14962]	['More than 60% reported their willingness to provide folic acid supplementation, though one in four stated they would not provide it.']	folic acid	CHEBI_EXT	[14882]	[14892]	PMC1184067_T41
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	Responsen	GO_BP_EXT	[15267]	[15276]	PMC1184067_T148
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	alcohol	CHEBI_EXT	[15401]	[15408]	PMC1184067_T42
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	intake90	GO_BP_EXT	[15409]	[15417]	PMC1184067_T149
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	caffeine	CHEBI_EXT	[15528]	[15536]	PMC1184067_T43
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	intake42	GO_BP_EXT	[15537]	[15545]	PMC1184067_T150
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	Blood	UBERON_EXT	[15575]	[15580]	PMC1184067_T273
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	rubella	NCBITAXON_EXT	[15593]	[15600]	PMC1184067_T215
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	antibody41	GO_CC_EXT	[15601]	[15611]	PMC1184067_T185
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	calcium	CHEBI_EXT	[15652]	[15659]	PMC1184067_T44
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	pregnancy30	GO_BP_EXT	[15712]	[15723]	PMC1184067_T151
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	Folic acid	CHEBI_EXT	[15753]	[15763]	PMC1184067_T45
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	conception14	GO_BP_EXT	[15855]	[15867]	PMC1184067_T152
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	women	NCBITAXON_EXT	[16070]	[16075]	PMC1184067_T216
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	women	UBERON_EXT	[16070]	[16075]	PMC1184067_T274
PMC1184067	PMC1184067_84	[15084]	[16185]	["Caption (TABLE-WRAP): TABLE 5\n\nJapanese family physicians' willingness to provide preconception care in their practice (n = 268)Currently ProvideWilling to ProvideWould Not ProvideNo Responsen(%)n(%)n(%)n(%)Smoking cessation154(57.5)103(38.4)5(1.9)6(2.2)Screening for anemia103(38.4)145(54.1)11(4.1)9(3.4)Restricting alcohol intake90(33.6)143(53.4)26(9.7)9(3.4)Use of basal body temperature monitoring61(22.8)137(51.1)59(22.0)9(4.1)Restricting caffeine intake42(15.7)171(63.8)42(15.7)13(3.8)Blood testing for rubella antibody41(15.3)186(69.4)30(11.2)11(4.1)Increasing calcium intake37(13.8)18(70.1)34(12.7)9(3.4)Exercise during pregnancy30(11.2)165(61.6)57(21.3)16(6.0)Folic acid supplementation14(5.2)170(54.1)68(25.4)16(6.0)Timing of intercourse to maximize chances of conception14(5.2)114(42.5)122(45.5)18(6.7)\nThough the instrument did not have open-ended questions, a number of respondents (n = 69, 26%) provided comments indicating they had been unaware of the recommendation for women to take folic acid supplementation and they were pleased to learn from the survey about this important issue."]	folic acid	CHEBI_EXT	[16084]	[16094]	PMC1184067_T46
PMC1184067	PMC1184067_88	[16607]	[16734]	["[7] There has been much debate about whether Japanese family physicians should provide obstetric and other women's health care."]	women	NCBITAXON_EXT	[16714]	[16719]	PMC1184067_T217
PMC1184067	PMC1184067_88	[16607]	[16734]	["[7] There has been much debate about whether Japanese family physicians should provide obstetric and other women's health care."]	women	UBERON_EXT	[16714]	[16719]	PMC1184067_T275
PMC1184067	PMC1184067_92	[17078]	[17149]	['Japanese FP/GPs seem reluctant to inquire about human sexuality issues.']	human	NCBITAXON_EXT	[17126]	[17131]	PMC1184067_T218
PMC1184067	PMC1184067_93	[17149]	[17276]	['[23] In the current study, some reported they could not ask patients about future pregnancy plans during a routine acute visit.']	pregnancy	GO_BP_EXT	[17231]	[17240]	PMC1184067_T153
PMC1184067	PMC1184067_94	[17277]	[17559]	['Our results show FP/GPs in Japan are not accustomed to addressing preconception-related topics (timing of intercourse, folic acid supplementation, exercise during pregnancy), while they are familiar with more general topics (smoking cessation, screening for anemia, calcium intake).']	preconception	GO_BP_EXT	[17343]	[17356]	PMC1184067_T154
PMC1184067	PMC1184067_94	[17277]	[17559]	['Our results show FP/GPs in Japan are not accustomed to addressing preconception-related topics (timing of intercourse, folic acid supplementation, exercise during pregnancy), while they are familiar with more general topics (smoking cessation, screening for anemia, calcium intake).']	intercourse	GO_BP_EXT	[17383]	[17394]	PMC1184067_T155
PMC1184067	PMC1184067_94	[17277]	[17559]	['Our results show FP/GPs in Japan are not accustomed to addressing preconception-related topics (timing of intercourse, folic acid supplementation, exercise during pregnancy), while they are familiar with more general topics (smoking cessation, screening for anemia, calcium intake).']	folic acid	CHEBI_EXT	[17396]	[17406]	PMC1184067_T47
PMC1184067	PMC1184067_94	[17277]	[17559]	['Our results show FP/GPs in Japan are not accustomed to addressing preconception-related topics (timing of intercourse, folic acid supplementation, exercise during pregnancy), while they are familiar with more general topics (smoking cessation, screening for anemia, calcium intake).']	pregnancy	GO_BP_EXT	[17440]	[17449]	PMC1184067_T156
PMC1184067	PMC1184067_94	[17277]	[17559]	['Our results show FP/GPs in Japan are not accustomed to addressing preconception-related topics (timing of intercourse, folic acid supplementation, exercise during pregnancy), while they are familiar with more general topics (smoking cessation, screening for anemia, calcium intake).']	calcium	CHEBI_EXT	[17543]	[17550]	PMC1184067_T48
PMC1184067	PMC1184067_95	[17560]	[17737]	["FP/GPs are in the unique position to provide health care services to male and female patients of all ages,[24,25] and they have many opportunities to discuss patients' concerns."]	male	UBERON_EXT	[17629]	[17633]	PMC1184067_T276
PMC1184067	PMC1184067_95	[17560]	[17737]	["FP/GPs are in the unique position to provide health care services to male and female patients of all ages,[24,25] and they have many opportunities to discuss patients' concerns."]	female	UBERON_EXT	[17638]	[17644]	PMC1184067_T277
PMC1184067	PMC1184067_96	[17738]	[17864]	['For example, young parents do not often visit family physicians for their own health problems, but do come for their children.']	children	NCBITAXON_EXT	[17855]	[17863]	PMC1184067_T219
PMC1184067	PMC1184067_96	[17738]	[17864]	['For example, young parents do not often visit family physicians for their own health problems, but do come for their children.']	children	UBERON_EXT	[17855]	[17863]	PMC1184067_T278
PMC1184067	PMC1184067_97	[17865]	[17933]	['At these visits, family physicians can also discuss family planning.']	planning	GO_BP_EXT	[17924]	[17932]	PMC1184067_T157
PMC1184067	PMC1184067_98	[17934]	[18060]	["For this reason, FP/GPs in Japan need training in women's health care, even if they will not provide deliveries in the future."]	women	NCBITAXON_EXT	[17984]	[17989]	PMC1184067_T220
PMC1184067	PMC1184067_98	[17934]	[18060]	["For this reason, FP/GPs in Japan need training in women's health care, even if they will not provide deliveries in the future."]	women	UBERON_EXT	[17984]	[17989]	PMC1184067_T279
PMC1184067	PMC1184067_98	[17934]	[18060]	["For this reason, FP/GPs in Japan need training in women's health care, even if they will not provide deliveries in the future."]	deliveries	GO_BP_EXT	[18035]	[18045]	PMC1184067_T158
PMC1184067	PMC1184067_99	[18061]	[18190]	["We hope these data will provide a catalyst for dialogue among Japan's FP/GPs about regular provision of preconception counseling."]	preconception	GO_BP_EXT	[18165]	[18178]	PMC1184067_T159
PMC1184067	PMC1184067_100	[18191]	[18315]	['Remarkably, only 10 % of participants reported knowledge of folic acid supplementation and few reported providing this care.']	folic acid	CHEBI_EXT	[18251]	[18261]	PMC1184067_T49
PMC1184067	PMC1184067_101	[18316]	[18384]	['Yamanaka surveyed pregnant women about the importance of folic acid.']	pregnant	GO_BP_EXT	[18334]	[18342]	PMC1184067_T160
PMC1184067	PMC1184067_101	[18316]	[18384]	['Yamanaka surveyed pregnant women about the importance of folic acid.']	women	NCBITAXON_EXT	[18343]	[18348]	PMC1184067_T221
PMC1184067	PMC1184067_101	[18316]	[18384]	['Yamanaka surveyed pregnant women about the importance of folic acid.']	folic acid	CHEBI_EXT	[18373]	[18383]	PMC1184067_T50
PMC1184067	PMC1184067_103	[18512]	[18729]	['Furthermore, the small percentage of participants who knew well about the importance of folic acid reported that they learned it from a newspaper, TV, or magazine, while only 16% learned it from medical professionals.']	folic acid	CHEBI_EXT	[18600]	[18610]	PMC1184067_T51
PMC1184067	PMC1184067_103	[18512]	[18729]	['Furthermore, the small percentage of participants who knew well about the importance of folic acid reported that they learned it from a newspaper, TV, or magazine, while only 16% learned it from medical professionals.']	learned	GO_BP_EXT	[18630]	[18637]	PMC1184067_T161
PMC1184067	PMC1184067_103	[18512]	[18729]	['Furthermore, the small percentage of participants who knew well about the importance of folic acid reported that they learned it from a newspaper, TV, or magazine, while only 16% learned it from medical professionals.']	learned	GO_BP_EXT	[18691]	[18698]	PMC1184067_T162
PMC1184067	PMC1184067_104	[18730]	[18862]	['Based on these data, Yamanaka emphasized that medical professionals should provide correct and concise information about folic acid.']	folic acid	CHEBI_EXT	[18851]	[18861]	PMC1184067_T52
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	folic acid	CHEBI_EXT	[18901]	[18911]	PMC1184067_T53
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	reproductive	GO_BP_EXT	[18931]	[18943]	PMC1184067_T163
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	aged	GO_BP_EXT	[18944]	[18948]	PMC1184067_T164
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	women	NCBITAXON_EXT	[18949]	[18954]	PMC1184067_T222
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	women	UBERON_EXT	[18949]	[18954]	PMC1184067_T280
PMC1184067	PMC1184067_105	[18863]	[19069]	['As the MHLW only recently recommended folic acid supplementation to reproductive-aged women,[15] it is not too surprising that many FP/GPs do not know the importance of folic acid and few provide this care.']	folic acid	CHEBI_EXT	[19032]	[19042]	PMC1184067_T54
PMC1184067	PMC1184067_107	[19161]	[19363]	["Based on these data it is clear that its membership is interested in women's health issues and should be included in notifications about women's health policy changes formulated at the government level."]	women	NCBITAXON_EXT	[19230]	[19235]	PMC1184067_T223
PMC1184067	PMC1184067_107	[19161]	[19363]	["Based on these data it is clear that its membership is interested in women's health issues and should be included in notifications about women's health policy changes formulated at the government level."]	women	UBERON_EXT	[19230]	[19235]	PMC1184067_T281
PMC1184067	PMC1184067_107	[19161]	[19363]	["Based on these data it is clear that its membership is interested in women's health issues and should be included in notifications about women's health policy changes formulated at the government level."]	women	NCBITAXON_EXT	[19298]	[19303]	PMC1184067_T224
PMC1184067	PMC1184067_107	[19161]	[19363]	["Based on these data it is clear that its membership is interested in women's health issues and should be included in notifications about women's health policy changes formulated at the government level."]	women	UBERON_EXT	[19298]	[19303]	PMC1184067_T282
PMC1184067	PMC1184067_108	[19364]	[19523]	['About 70% of participants reported they are willing to screen women for rubella antibody, though almost 70% reported not providing this care in their practice.']	women	NCBITAXON_EXT	[19426]	[19431]	PMC1184067_T225
PMC1184067	PMC1184067_108	[19364]	[19523]	['About 70% of participants reported they are willing to screen women for rubella antibody, though almost 70% reported not providing this care in their practice.']	women	UBERON_EXT	[19426]	[19431]	PMC1184067_T283
PMC1184067	PMC1184067_108	[19364]	[19523]	['About 70% of participants reported they are willing to screen women for rubella antibody, though almost 70% reported not providing this care in their practice.']	rubella	NCBITAXON_EXT	[19436]	[19443]	PMC1184067_T226
PMC1184067	PMC1184067_108	[19364]	[19523]	['About 70% of participants reported they are willing to screen women for rubella antibody, though almost 70% reported not providing this care in their practice.']	antibody	GO_CC_EXT	[19444]	[19452]	PMC1184067_T186
PMC1184067	PMC1184067_109	[19524]	[19683]	['Given the historic mistrust of the rubella vaccine and the low rate of vaccination in Japan,[16] Japanese family doctors need to proactively address the topic.']	vaccine	CHEBI_EXT	[19567]	[19574]	PMC1184067_T55
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	women	NCBITAXON_EXT	[19789]	[19794]	PMC1184067_T227
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	women	UBERON_EXT	[19789]	[19794]	PMC1184067_T284
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	childbearing	GO_BP_EXT	[19798]	[19810]	PMC1184067_T165
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	childbearing	UBERON_EXT	[19798]	[19810]	PMC1184067_T285
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	rubella	NCBITAXON_EXT	[19825]	[19832]	PMC1184067_T228
PMC1184067	PMC1184067_110	[19684]	[19866]	['The lack of mandatory vaccination is a loophole in public health policy[16] and highlights why screening women of childbearing potential for rubella antibody is especially important.']	antibody	GO_CC_EXT	[19833]	[19841]	PMC1184067_T187
PMC1184067	PMC1184067_112	[19986]	[20070]	['Non-immune pregnant women should post-pone rubella vaccination until after delivery.']	pregnant	GO_BP_EXT	[19997]	[20005]	PMC1184067_T166
PMC1184067	PMC1184067_112	[19986]	[20070]	['Non-immune pregnant women should post-pone rubella vaccination until after delivery.']	women	NCBITAXON_EXT	[20006]	[20011]	PMC1184067_T229
PMC1184067	PMC1184067_112	[19986]	[20070]	['Non-immune pregnant women should post-pone rubella vaccination until after delivery.']	delivery	GO_BP_EXT	[20061]	[20069]	PMC1184067_T167
PMC1184067	PMC1184067_113	[20071]	[20188]	["Japan's FP/GPs must learn to provide preconception counseling in order to close this important gap in women's health."]	preconception	GO_BP_EXT	[20108]	[20121]	PMC1184067_T168
PMC1184067	PMC1184067_113	[20071]	[20188]	["Japan's FP/GPs must learn to provide preconception counseling in order to close this important gap in women's health."]	women	NCBITAXON_EXT	[20173]	[20178]	PMC1184067_T230
PMC1184067	PMC1184067_113	[20071]	[20188]	["Japan's FP/GPs must learn to provide preconception counseling in order to close this important gap in women's health."]	women	UBERON_EXT	[20173]	[20178]	PMC1184067_T286
PMC1184067	PMC1184067_115	[20381]	[20516]	["Japan's FP/GPs need educational materials and clinical tools to encourage women to make an office visit and receive preconception care."]	women	NCBITAXON_EXT	[20455]	[20460]	PMC1184067_T231
PMC1184067	PMC1184067_115	[20381]	[20516]	["Japan's FP/GPs need educational materials and clinical tools to encourage women to make an office visit and receive preconception care."]	women	UBERON_EXT	[20455]	[20460]	PMC1184067_T287
PMC1184067	PMC1184067_115	[20381]	[20516]	["Japan's FP/GPs need educational materials and clinical tools to encourage women to make an office visit and receive preconception care."]	preconception	GO_BP_EXT	[20497]	[20510]	PMC1184067_T169
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	adult	UBERON_EXT	[20570]	[20575]	PMC1184067_T288
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	prenatal	GO_BP_EXT	[20623]	[20631]	PMC1184067_T170
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	newborn	UBERON_EXT	[20633]	[20640]	PMC1184067_T289
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	children	NCBITAXON_EXT	[20642]	[20650]	PMC1184067_T232
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	children	UBERON_EXT	[20642]	[20650]	PMC1184067_T290
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	adolescent	UBERON_EXT	[20652]	[20662]	PMC1184067_T291
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	women	NCBITAXON_EXT	[20667]	[20672]	PMC1184067_T233
PMC1184067	PMC1184067_116	[20517]	[20682]	["Family medicine training in Japan heavily emphasizes adult and geriatric medicine with little emphasis on prenatal, newborn, children, adolescent, or women's health."]	women	UBERON_EXT	[20667]	[20672]	PMC1184067_T292
PMC1184067	PMC1184067_118	[20867]	[21069]	['Data from Japanese women from Japan who are on temporary assignment in the United States, illustrate low levels of knowledge about prenatal folic acid supplementation and resistance to take supplements.']	women	NCBITAXON_EXT	[20886]	[20891]	PMC1184067_T234
PMC1184067	PMC1184067_118	[20867]	[21069]	['Data from Japanese women from Japan who are on temporary assignment in the United States, illustrate low levels of knowledge about prenatal folic acid supplementation and resistance to take supplements.']	women	UBERON_EXT	[20886]	[20891]	PMC1184067_T293
PMC1184067	PMC1184067_118	[20867]	[21069]	['Data from Japanese women from Japan who are on temporary assignment in the United States, illustrate low levels of knowledge about prenatal folic acid supplementation and resistance to take supplements.']	prenatal	GO_BP_EXT	[20998]	[21006]	PMC1184067_T171
PMC1184067	PMC1184067_118	[20867]	[21069]	['Data from Japanese women from Japan who are on temporary assignment in the United States, illustrate low levels of knowledge about prenatal folic acid supplementation and resistance to take supplements.']	folic acid	CHEBI_EXT	[21007]	[21017]	PMC1184067_T56
PMC1184067	PMC1184067_122	[21488]	[21663]	["If this interpretation is correct, the need for public campaigns about the importance of preconception care and training of Japan's family physicians are even more imperative."]	preconception	GO_BP_EXT	[21577]	[21590]	PMC1184067_T172
PMC1184067	PMC1184067_123	[21664]	[21990]	["Despite compelling evidence of the effectiveness of folic acid supplementation and other preconception care for the reduction of serious birth defects at a very low cost, these data provide evidence that the WHO's message about the importance has not filtered down to the clinical level even in a developed country like Japan."]	folic acid	CHEBI_EXT	[21716]	[21726]	PMC1184067_T57
PMC1184067	PMC1184067_123	[21664]	[21990]	["Despite compelling evidence of the effectiveness of folic acid supplementation and other preconception care for the reduction of serious birth defects at a very low cost, these data provide evidence that the WHO's message about the importance has not filtered down to the clinical level even in a developed country like Japan."]	preconception	GO_BP_EXT	[21753]	[21766]	PMC1184067_T173
PMC1184067	PMC1184067_123	[21664]	[21990]	["Despite compelling evidence of the effectiveness of folic acid supplementation and other preconception care for the reduction of serious birth defects at a very low cost, these data provide evidence that the WHO's message about the importance has not filtered down to the clinical level even in a developed country like Japan."]	birth	GO_BP_EXT	[21801]	[21806]	PMC1184067_T174
PMC1184067	PMC1184067_124	[21991]	[22117]	["Continued efforts to spread and diffuse the WHO's message are desperately needed for the advancement of maternal-child health."]	child	NCBITAXON_EXT	[22104]	[22109]	PMC1184067_T235
PMC1184067	PMC1184067_124	[21991]	[22117]	["Continued efforts to spread and diffuse the WHO's message are desperately needed for the advancement of maternal-child health."]	child	UBERON_EXT	[22104]	[22109]	PMC1184067_T294
PMC1184067	PMC1184067_125	[22119]	[22246]	["Conclusion\nOur study reveals that many Japan's FP/GPs have limited training in preconception care and few currently provide it."]	preconception	GO_BP_EXT	[22198]	[22211]	PMC1184067_T175
PMC1184067	PMC1184067_126	[22247]	[22423]	['Most participants report their willingness to provide preconception care themselves and educational campaigns are needed to enhance preventive care provided by FP/GPs in Japan.']	preconception	GO_BP_EXT	[22301]	[22314]	PMC1184067_T176
PMC1184067	PMC1184067_127	[22425]	[22903]	['List of abbreviations used\nCBC  complete blood count\nFP/GPs  family physicians and general practitioners\nIgG  immunoglobulin G\nJAFM  Japanese Academy of Family Medicine\nmg  milligrams\nMHLW  Ministry of Health, Labour and Welfare\nOB/GYN  obstetrics and gynecology\nRCT  randomized controlled trial\nSPSS  Statistical Package for the Social Sciences\nWHO  World Health Organization\nwk  week\n\nCompeting interests\nThe author(s) declare that they have no competing interests.']	blood	UBERON_EXT	[22467]	[22472]	PMC1184067_T295
PMC1184067	PMC1184067_127	[22425]	[22903]	['List of abbreviations used\nCBC  complete blood count\nFP/GPs  family physicians and general practitioners\nIgG  immunoglobulin G\nJAFM  Japanese Academy of Family Medicine\nmg  milligrams\nMHLW  Ministry of Health, Labour and Welfare\nOB/GYN  obstetrics and gynecology\nRCT  randomized controlled trial\nSPSS  Statistical Package for the Social Sciences\nWHO  World Health Organization\nwk  week\n\nCompeting interests\nThe author(s) declare that they have no competing interests.']	IgG	GO_CC_EXT	[22532]	[22535]	PMC1184067_T188
PMC1184067	PMC1184067_127	[22425]	[22903]	['List of abbreviations used\nCBC  complete blood count\nFP/GPs  family physicians and general practitioners\nIgG  immunoglobulin G\nJAFM  Japanese Academy of Family Medicine\nmg  milligrams\nMHLW  Ministry of Health, Labour and Welfare\nOB/GYN  obstetrics and gynecology\nRCT  randomized controlled trial\nSPSS  Statistical Package for the Social Sciences\nWHO  World Health Organization\nwk  week\n\nCompeting interests\nThe author(s) declare that they have no competing interests.']	immunoglobulin	GO_CC_EXT	[22538]	[22552]	PMC1184067_T189
